AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

NCT05404906 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML) in Remission

Interventions

DRUG: Azacitidine
DRUG: Venetoclax
OTHER: Supportive care

Sponsor

The First Affiliated Hospital of Soochow University